1-36322521-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001304762.2(EVA1B):c.272C>T(p.Pro91Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000575 in 1,600,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001304762.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVA1B | NM_001304762.2 | c.272C>T | p.Pro91Leu | missense_variant | 3/3 | ENST00000490466.2 | NP_001291691.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVA1B | ENST00000490466.2 | c.272C>T | p.Pro91Leu | missense_variant | 3/3 | 2 | NM_001304762.2 | ENSP00000507013.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000951 AC: 21AN: 220826Hom.: 0 AF XY: 0.0000980 AC XY: 12AN XY: 122412
GnomAD4 exome AF: 0.0000504 AC: 73AN: 1448562Hom.: 0 Cov.: 37 AF XY: 0.0000555 AC XY: 40AN XY: 720918
GnomAD4 genome AF: 0.000125 AC: 19AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.272C>T (p.P91L) alteration is located in exon 3 (coding exon 2) of the EVA1B gene. This alteration results from a C to T substitution at nucleotide position 272, causing the proline (P) at amino acid position 91 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at